Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

0.05% betamethasone dipropionate is the most effective treatment for mild alopecia areata.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Oral cyclosporine works better than betamethasone minipulse therapy for treating Alopecia Areata.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Certain medications can cause serious side effects, so it's important to report them.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

ITK inhibitors may effectively treat alopecia areata.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

CD19-CAR T cell therapy may help regenerate skin in systemic sclerosis.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Zinc supplementation effectively treats acrodermatitis enteropathica symptoms.

Ixekizumab has known and some unexpected side effects.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.